# Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study

> **NCT00421863** · PHASE4 · COMPLETED · sponsor: **Heart Care Foundation** · enrollment: 1111 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Triatec 10 mg
- **DRUG:** Triatec HCT 5
- **DRUG:** Lasix 25
- **DRUG:** Micardis 80 mg
- **DRUG:** Micardis plus 80/12.5
- **DRUG:** Catapresan TTS 2
- **DRUG:** Norvasc 10 mg
- **DRUG:** Triatec 5 mg
- **DRUG:** Pluscor

## Key facts

- **NCT ID:** NCT00421863
- **Lead sponsor:** Heart Care Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 1111 (ACTUAL)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421863, "Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00421863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*